Alize reports positive clinical results

Graftys : initiation of post Marketing Surveillance program
16 November 2015
ORPHELIA Pharma strengthens its development operations
9 October 2015

Alize reports positive clinical results

Safety and efficacy results from a Phase Ib trial support further development of AZP-531 in type 2 diabetes.